Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: IQ-AI Partners With Mayo Clinic For Brain Lesion Technology

9th Nov 2020 15:16

IQ-AI Ltd - medical software company with headquarters in Jersey - Says unit Imaging Biometrics LLC enters into agreement with Mayo Clinic for development of brain lesion tracking platform, IB Trax. IQ-AI to issue Mayo USD50,000 worth of shares before effective date of agreement then will issue USD10,000 worth of stock on first anniversary of pact and every year thereafter as long as agreement is still in place.

Current stock price: 13.02 pence, down 10% on Monday

Year-to-date change: up sharply from 3.95p

By Eric Cunha; [email protected]

Copyright 2020 Alliance News Limited. All Rights Reserved.


Related Shares:

IQ-AI
FTSE 100 Latest
Value8,809.74
Change53.53